|
AZIN1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.7412737918221E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.82990314409903E-11 |
| Normal-vs-Stage2 |
8.04080002581031E-09 |
| Normal-vs-Stage3 |
1.49558143647255E-12 |
| Normal-vs-Stage4 |
1.09459996622263E-10 |
| Stage1-vs-Stage2 |
2.406200E-01 |
| Stage1-vs-Stage3 |
2.823800E-02 |
| Stage1-vs-Stage4 |
5.254300E-02 |
| Stage2-vs-Stage3 |
6.685000E-01 |
| Stage2-vs-Stage4 |
5.397000E-01 |
| Stage3-vs-Stage4 |
8.147800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.37427871702312E-14 |
| Normal-vs-AfricanAmerican |
2.259900E-02 |
| Normal-vs-Asian |
2.14049999947008E-08 |
| Caucasian-vs-AfricanAmerican |
2.403800E-01 |
| Caucasian-vs-Asian |
8.450200E-01 |
| AfricanAmerican-vs-Asian |
2.364800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.41553435639707E-13 |
| Normal-vs-Female |
1.19589893543548E-11 |
| Male-vs-Female |
7.119600E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.33279995110314E-09 |
| Normal-vs-Age(41-60Yrs) |
1.06581410364015E-14 |
| Normal-vs-Age(61-80Yrs) |
3.4079999933212E-09 |
| Normal-vs-Age(81-100Yrs) |
9.552800E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.027800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.709000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.860000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.359600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.591200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.787200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.154300E-02 |
| Classical-VS-Follicular |
9.853000E-01 |
| Classical-VS-Other |
6.129400E-01 |
| Classical-VS-Normal |
1.94899651972946E-11 |
| Tall-VS-Follicular |
1.324600E-01 |
| Tall-VS-Other |
7.851200E-01 |
| Tall-VS-Normal |
1.83619996985129E-09 |
| Follicular-VS-Other |
6.409400E-01 |
| Follicular-VS-Normal |
4.65220000300803E-08 |
| Other-VS-Normal |
3.223100E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.19120047159527E-10 |
| Normal-vs-N1 |
5.93439963836317E-10 |
| N0-vs-N1 |
2.328200E-01 |
|
|
